H.C. Wainwright Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $7

H.C. Wainwright analyst Robert Burns initiates coverage on $Immix Biopharma(IMMX.US)$ with a buy rating, and sets the target price at $7.According to TipRanks data, the analyst has a success rate of 2

Futu NewsJul 1 18:31 · Ratings

Immix Biopharma Price Target Announced at $7.00/Share by HC Wainwright & Co.

Immix Biopharma Price Target Announced at $7.00/Share by HC Wainwright & Co.

Dow JonesJul 1 18:20

Immix Biopharma Initiated at Buy by HC Wainwright & Co.

Immix Biopharma Initiated at Buy by HC Wainwright & Co.

Dow JonesJul 1 18:20

Buy Rating for Immix Biopharma Backed by Promising N-GENIUS Platform and Strong NXC-201 Sales Potential

TipRanksJul 1 18:16

Immix Biopharma Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 278.38% HC Wainwright & Co. → $7 Initiates Coverage On → Buy 08/14/2023 656.76% Roth MKM → $14

BenzingaJul 1 18:08

Express News | Immix Biopharma, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $7

BreakingsJul 1 18:04